90 related articles for article (PubMed ID: 16888154)
1. Effect of VIP on TLR2 and TLR4 expression in lymph node immune cells during TNBS-induced colitis.
Arranz A; Abad C; Juarranz Y; Torroba M; Rosignoli F; Leceta J; Gomariz RP; Martínez C
Ann N Y Acad Sci; 2006 Jul; 1070():129-34. PubMed ID: 16888154
[TBL] [Abstract][Full Text] [Related]
2. VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4.
Arranz A; Juarranz Y; Leceta J; Gomariz RP; Martínez C
Peptides; 2008 Jun; 29(6):948-56. PubMed ID: 18359536
[TBL] [Abstract][Full Text] [Related]
3. Time-course expression of Toll-like receptors 2 and 4 in inflammatory bowel disease and homeostatic effect of VIP.
Gomariz RP; Arranz A; Abad C; Torroba M; Martinez C; Rosignoli F; Garcia-Gómez M; Leceta J; Juarranz Y
J Leukoc Biol; 2005 Aug; 78(2):491-502. PubMed ID: 15857940
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
6. Loss of Toll-like receptor 2 and 4 leads to differential induction of endoplasmic reticulum stress and proapoptotic responses in the intestinal epithelium under conditions of chronic inflammation.
Messlik A; Schmechel S; Kisling S; Bereswill S; Heimesaat MM; Fischer A; Göbel U; Haller D
J Proteome Res; 2009 Oct; 8(10):4406-17. PubMed ID: 19681597
[TBL] [Abstract][Full Text] [Related]
7. Pivotal advance: vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages.
Foster N; Lea SR; Preshaw PM; Taylor JJ
J Leukoc Biol; 2007 Apr; 81(4):893-903. PubMed ID: 16973891
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-11 reduces TLR4-induced colitis in TLR2-deficient mice and restores intestinal STAT3 signaling.
Gibson DL; Montero M; Ropeleski MJ; Bergstrom KS; Ma C; Ghosh S; Merkens H; Huang J; Månsson LE; Sham HP; McNagny KM; Vallance BA
Gastroenterology; 2010 Oct; 139(4):1277-88. PubMed ID: 20600022
[TBL] [Abstract][Full Text] [Related]
9. A transient breach in the epithelial barrier leads to regulatory T-cell generation and resistance to experimental colitis.
Boirivant M; Amendola A; Butera A; Sanchez M; Xu L; Marinaro M; Kitani A; Di Giacinto C; Strober W; Fuss IJ
Gastroenterology; 2008 Nov; 135(5):1612-1623.e5. PubMed ID: 18765239
[TBL] [Abstract][Full Text] [Related]
10. Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease.
Szebeni B; Veres G; Dezsofi A; Rusai K; Vannay A; Bokodi G; Vásárhelyi B; Korponay-Szabó IR; Tulassay T; Arató A
J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):187-93. PubMed ID: 17667714
[TBL] [Abstract][Full Text] [Related]
11. [Effects of vasoactive intestinal peptide on Toll-like receptor (TLR) 2 mRNA and TLR4 mRNA expression on acute lung injury induced by lipopolysaccharide in rat].
Zuo WQ; Zhang YC; Gong XH; Zhang YM
Zhonghua Er Ke Za Zhi; 2010 Jan; 48(1):19-23. PubMed ID: 20441697
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide as a healing mediator in Crohn's disease.
Arranz A; Abad C; Juarranz Y; Leceta J; Martinez C; Gomariz RP
Neuroimmunomodulation; 2008; 15(1):46-53. PubMed ID: 18667799
[TBL] [Abstract][Full Text] [Related]
13. The presentation of haptenated proteins and activation of T cells in the mesenteric lymph nodes by dendritic cells in the TNBS colitis rat.
Ishiguro Y; Sakuraba H; Yamagata K; Munakata A
Ann N Y Acad Sci; 2004 Dec; 1029():346-7. PubMed ID: 15681777
[TBL] [Abstract][Full Text] [Related]
14. Polyamines are required for expression of Toll-like receptor 2 modulating intestinal epithelial barrier integrity.
Chen J; Rao JN; Zou T; Liu L; Marasa BS; Xiao L; Zeng X; Turner DJ; Wang JY
Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G568-76. PubMed ID: 17600044
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the colonic epithelial cell responses and amelioration of inflammation by CD80 blockade in TNBS colitis.
Srinivasan M; Summerlin DJ
Clin Immunol; 2009 Dec; 133(3):411-21. PubMed ID: 19811954
[TBL] [Abstract][Full Text] [Related]
16. VIP decreases TLR4 expression induced by LPS and TNF-alpha treatment in human synovial fibroblasts.
Juarranz Y; Gutiérrez-Cañas I; Arranz A; Martínez C; Abad C; Leceta J; Pablos JL; Gomariz RP
Ann N Y Acad Sci; 2006 Jul; 1070():359-64. PubMed ID: 16888192
[TBL] [Abstract][Full Text] [Related]
17. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
18. Local overexpression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: synergism of TLR2 and TLR4.
Shinohara M; Hirata K; Yamashita T; Takaya T; Sasaki N; Shiraki R; Ueyama T; Emoto N; Inoue N; Yokoyama M; Kawashima S
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2384-91. PubMed ID: 17872459
[TBL] [Abstract][Full Text] [Related]
19. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
20. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
